https://www.selleckchem.com/pr....oducts/uamc-3203.htm
006). This finding persisted regardless of threshold used and across subgroup analyses according to PD-L1 assay type, tumor histology, line of therapy, type of inhibitor and study methodology. CONCLUSIONS PD-L1 levels have important predictive value in determining the response to immunotherapy. However, patients with low PD-L1 levels also experience improved survival with immunotherapy compared with standard treatment. © The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail journ
Like
Comment
Share
